已选(0)清除
条数/页: 排序方式: |
| Evolutionary analysis and lineage designation of SARS-CoV-2 genomes 期刊论文 Science Bulletin, 2021 作者: Tang X.; Ying R.; Yao X.; Li G.; Wu C.; Tang Y.; Li Z.; Kuang B.; Wu F.; Chi C.; Du X.; Qin Y.; Gao S.; Hu S.; Ma J.; Liu T.; Pang X.; Wang J.; Zhao G.; Tan W.; Zhang Y.; Lu X.; Lu J. 收藏  |  浏览/下载:30/0  |  提交时间:2021/09/01 Adaptive evolution Compensatory advantageous mutation COVID-19 Evolutionary analysis Lineage designation |
| Electron-plasmon interaction induced plasmonic-polaron band replication in epitaxial perovskite SrIrO3 films 期刊论文 Science Bulletin, 2021, 卷号: 66, 期号: 5 作者: Liu Z.; Liu W.; Zhou R.; Cai S.; Song Y.; Yao Q.; Lu X.; Liu J.; Liu Z.; Wang Z.; Zheng Y.; Wang P.; Liu Z.; Li G.; Shen D. 收藏  |  浏览/下载:27/0  |  提交时间:2021/09/01 5d electron systems Electron-plasmon interaction perovskite SrIrO3 Replica bands |
| Identification of an allosteric hotspot for additive activation of PPARγ in antidiabetic effects 期刊论文 Science Bulletin, 2021, 卷号: 66, 期号: 15 作者: Feng L.; Lu S.; Zheng Z.; Chen Y.; Zhao Y.; Song K.; Xue H.; Jin L.; Li Y.; Huang C.; Li Y.-M.; Zhang J. 收藏  |  浏览/下载:36/0  |  提交时间:2021/09/01 Additive activation Allosteric hotspot Cobinding Combination therapy PPARγ Side effects |
| Global observation of urban expansion and land-cover dynamics using satellite big-data 期刊论文 Science Bulletin, 2021, 卷号: 66, 期号: 4 作者: Kuang W.; Du G.; Lu D.; Dou Y.; Li X.; Zhang S.; Chi W.; Dong J.; Chen G.; Yin Z.; Pan T.; Hamdi R.; Hou Y.; Chen C.; Li H.; Miao C. 收藏  |  浏览/下载:33/0  |  提交时间:2021/09/01 |
| Molecular taxonomy of the primate amygdala via single-nucleus RNA sequencing analysis 期刊论文 Science Bulletin, 2021, 卷号: 66, 期号: 14 作者: Zhang L.; Cheng Y.; Wu S.; Lu Y.; Xue Z.; Chen X.; Chen D.; Zhang B.; Qiu Z.; Jiang H. 收藏  |  浏览/下载:44/0  |  提交时间:2021/09/01 |
| Human activities have altered fire-climate relations in arid Central Asia since ~1000 a BP: evidence from a 4200-year-old sedimentary archive 期刊论文 Science Bulletin, 2021, 卷号: 66, 期号: 8 作者: Zhang S.; Lu Y.; Wei W.; Qiu M.; Dong G.; Liu X. 收藏  |  浏览/下载:22/0  |  提交时间:2021/09/01 |
| Corrigendum to “Tauroursodeoxycholic acid (TUDCA) inhibits influenza A viral infection by disrupting viral proton channel M2” [Sci. Bull., 64 (3) (2019) 180–188](S2095927318304134)(10.1016/j.scib.2018.08.013) 期刊论文 Science Bulletin, 2021, 卷号: 66, 期号: 4 作者: Li N.; Zhang Y.; Wu S.; Xu R.; Li Z.; Zhu J.; Wang H.; Li X.; Tian M.; Lu H.; Jin N.; Jiang C. 收藏  |  浏览/下载:15/0  |  提交时间:2021/09/01 |
| Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP) 期刊论文 Science Bulletin, 2021, 卷号: 66, 期号: 15 作者: Ji L.; Song W.; Fang H.; Li W.; Geng J.; Wang Y.; Guo L.; Cai H.; Yang T.; Li H.; Yang G.; Li Q.; Liu K.; Li S.; Liu Y.; Shi F.; Li X.; Gao X.; Tian H.; Ji Q.; Su Q.; Zhou Z.; Wang W.; Zhou Z.; Li X.; Xu Y.; Ning Z.; Cao H.; Pan D.; Yao H.; Lu X.; Jia W. 收藏  |  浏览/下载:37/0  |  提交时间:2021/09/01 Carfloglitazar Chiglitazar Glycemic control Insulin resistance PPAR pan-agonist Type 2 diabetes |
| Momentum-space imaging spectroscopy for the study of nanophotonic materials 期刊论文 Science Bulletin, 2021, 卷号: 66, 期号: 8 作者: Zhang Y.; Zhao M.; Wang J.; Liu W.; Wang B.; Hu S.; Lu G.; Chen A.; Cui J.; Zhang W.; Hsu C.W.; Liu X.; Shi L.; Yin H.; Zi J. 收藏  |  浏览/下载:103/0  |  提交时间:2021/09/01 Momentum space imaging Nanophotonic material Photonic dispersion Photonic eigenmode Polarization state Quality factor |
| Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS) 期刊论文 Science Bulletin, 2021, 卷号: 66, 期号: 15 作者: Jia W.; Ma J.; Miao H.; Wang C.; Wang X.; Li Q.; Lu W.; Yang J.; Zhang L.; Yang J.; Wang G.; Zhang X.; Zhang M.; Sun L.; Yu X.; Du J.; Shi B.; Xiao C.; Zhu D.; Liu H.; Zhong L.; Xu C.; Xu Q.; Liang G.; Zhang Y.; Li G.; Gu M.; Liu J.; Yuan G.; Yan Z.; Yan D.; Ye S.; Zhang F.; Ning Z.; Cao H.; Pan D.; Yao H.; Lu X.; Ji L. 收藏  |  浏览/下载:39/0  |  提交时间:2021/09/01 Chiglitazar Glycemic control Insulin resistance PPAR pan-agonist Type 2 diabetes |